Ganymede Bio and Kytopen to bring cloud-native structured data to gene-modified cell therapy
![Laboratory automation, biotechnology](/sites/default/files/styles/content_banner/public/2023-09/motorolka%20shutterstock_1667119063.jpg?h=95acd807&itok=X2anGApc)
Credit: motorolka/Shutterstock
Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, and Kytopen, a leader in the development and commercialisation of non-viral transfection tools for genome engineering, today announced a partnership to bring the power of cloud native, structured data to Kytopen’s Flowfect platforms. Under this collaboration, the Kytopen transfection systems will integrate Ganymede’s Lab-as-Code platform for:
Welcome to Scientific Computing World
Already registered? Sign in to continue reading
Not got an account? Register for free to continue reading